Stomach cancer is a type of cancer that affects the lining of the stomach. It is a serious and life-threatening condition, but it can be treated if caught early. Unfortunately, many cases of stomach cancer go undetected until the cancer has advanced and become more difficult to treat. It is important for doctors to be aware of the subtle signs and symptoms of stomach cancer so that they can diagnose and treat it as soon as possible.
Stomach cancer is more common among people over the age of 50, although it can affect people of all ages. Other risk factors for stomach cancer include a family history of the disease, a diet high in smoked, salty, or pickled foods, and long-term infection with bacteria such as Helicobacter pylori. Smoking and excessive alcohol consumption are also risk factors for stomach cancer.
The signs and symptoms of stomach cancer can be subtle and may not be noticed until the cancer has advanced. Common symptoms include abdominal pain, nausea, vomiting, loss of appetite, weight loss, fatigue, and a feeling of fullness in the abdomen. Additionally, some people may experience blood in their stool, a change in bowel habits, or a lump in the abdomen.
If a doctor suspects that a patient may have stomach cancer, they will order tests such as an endoscopy, a CT scan, an MRI, or a biopsy to confirm the diagnosis. Once the diagnosis is confirmed, the doctor will develop a treatment plan. Treatment options may include surgery, chemotherapy, radiation therapy, or a combination of these.
Stomach cancer is a serious and life-threatening condition, but it can be treated if caught early. Unfortunately, many cases of stomach cancer go undetected until the cancer has advanced and become more difficult to treat. It is important for doctors to be aware of the subtle signs and symptoms of stomach cancer so that they can diagnose and treat it as soon as possible. Early diagnosis and treatment can improve the chances of successful treatment and a positive outcome.
1.
Report provides global picture of wide inequalities in care for women's cancers
2.
A hint regarding aspirin, the connection to colon cancer, the approval of the new Lutathera, artificial intelligence, and electronic records.
3.
Kate Middleton and Remission: Oncologists Weigh In
4.
In a randomized trial, the kinder, gentler regimen for classical Hodgkin wins out.
5.
Mental health risk persists years after cancer diagnosis
1.
The Basics of Langerhans Cell Histiocytosis: Understanding a Rare Disease
2.
Esophageal Cancer Survival Rates and Outcomes: Evidence-Based Insights from Oncology Studies
3.
A Revolutionary Guide to Calculating Absolute Neutrophil Counts
4.
Studying Lactic Acid in Pediatric Tumor Microenvironments: Experimental Approaches Explored
5.
Harnessing Artificial Intelligence in Oncology: Innovations in Diagnosis, Treatment, and Patient Care
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part V
2.
From Relapse to Remission Mapping the Treatment Journey in Adult R R B Cell ALL The Critical Goal of MRD
3.
The Landscape of First-Line Treatment for Urothelial Carcinoma- The Conclusion
4.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
5.
Summary of The Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation